| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1093/JNCI/94.18.1344 |
| P698 | PubMed publication ID | 12237273 |
| P50 | author | Gloria M Petersen | Q95972100 |
| P2093 | author name string | Stephen B Gruber | |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1344-1345 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Cancer risks in BRCA1 carriers: time for the next generation of studies | |
| P478 | volume | 94 |
| Q54521566 | Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin. |
| Q54409850 | BRCA1 mutations and colorectal cancer in Poland. |
| Q36610578 | Cancer risks among BRCA1 and BRCA2 mutation carriers |
| Q43232373 | Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations |
| Q89659606 | Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? |
| Q57735530 | Germline BRCA1 mutations predispose to pancreatic adenocarcinoma |
| Q84549013 | Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan |
| Q61812261 | Overview of the genetic basis toward early detection of breast cancer |
| Q57266547 | Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations |
| Q38294122 | Skin cancer risk in BRCA1/2 mutation carriers |
| Q35026396 | The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. |
Search more.